26.04.2015 Views

Eighth Edition - R.3 - Human Fertilisation & Embryology Authority

Eighth Edition - R.3 - Human Fertilisation & Embryology Authority

Eighth Edition - R.3 - Human Fertilisation & Embryology Authority

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

HFEA guidance (cont)<br />

Confidentiality<br />

12.12 In addition to following standard procedures for protecting patient and donor confidentiality, the centre<br />

should ensure it keeps all notes, facilities and procedures for the egg provider separate from those for the<br />

recipient(s). Care should be taken to ensure that confidentiality is not compromised, for example, if the egg<br />

provider and recipient(s) are treated at the same centre at the same time.<br />

See also guidance note:<br />

<br />

30 – Confidentiality and privacy<br />

Egg sharing agreements<br />

12.13 The centre should draw up separate agreements with the egg provider and with the egg recipient(s).<br />

These agreements should be consistent with each other. The centre should abide by the terms<br />

of egg sharing agreements it has made.<br />

Agreement between a licensed centre and an egg provider<br />

12.14 When drawing up agreements between the centre and egg providers, centres should seek legal advice.<br />

12.15 The agreement between the centre and the egg provider should set out all the terms of the arrangement.<br />

It should identify clearly the egg provider and the centre, and be signed by both parties.<br />

12.16 The agreement should include a statement confirming:<br />

(a) that any patient who has consented to providing eggs for the treatment of others<br />

in licensed treatment under the HFE Act 1990 (as amended) will not be the legal<br />

parent of any resulting child(ren)<br />

(b)<br />

(c)<br />

what information will be available to the egg provider about the recipient and the outcome of<br />

her treatment, for example the number and sex of any resulting children, and<br />

what information will be available to the egg recipient about the egg provider and the<br />

outcome of her treatment, for example the number and sex of any resulting children.<br />

12.17 The agreement should include a full description of what the treatment is expected to involve, including:<br />

(a) the number of treatment cycles covered by the agreement, and<br />

(b)<br />

the expected waiting time for treatment.<br />

12.18 The agreement should include a statement from the egg provider confirming that she has:<br />

(a) had an opportunity to talk with a member of staff qualified to explain the procedures involved<br />

in providing her eggs as part of an egg sharing arrangement<br />

(b)<br />

(c)<br />

(d)<br />

(e)<br />

received verbal and written information about her treatment<br />

received all the appropriate information listed in the relevant parts of this Code of Practice<br />

been offered counselling about the implications of the treatment, and<br />

been made aware of the screening that will be done before treatment begins.<br />

See also guidance notes:<br />

<br />

<br />

4 – Information to be provided prior to consent<br />

11 – Donor recruitment, assessment and screening<br />

<strong>Human</strong> <strong>Fertilisation</strong> and <strong>Embryology</strong> <strong>Authority</strong><br />

Guidance note | 12. Egg sharing arrangements<br />

Version 1.0

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!